Microwave Spectroscopy for Enantiomeric Detection of Chiral Molecules - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Microwave Spectroscopy for Enantiomeric Detection of Chiral Molecules
Microwave spectroscopy overcomes some of the limitations of circular dichroism and vibrational circular dichroism in analyzing enantiomers.


Pharmaceutical Technology
Volume 37, Issue 6, pp. 46

Chirality plays an important role in pharmaceutical compounds, and methods for detecting and quantifying chirality remains challenging. Researchers at Harvard University and the Center for Free-Electron Laser Science (CFEL) and the Max Planck Institute in Germany recently reported on the use of enantiomer-specific detection of chiral molecules by microwave spectroscopy.

The researchers pointed out that the spectroscopic methods of circular dichroism and vibrational circular dichroism are commonly used in analyzing chiral molecules. These methods, however, have limitations in electric dipole approximation as the resultant weak effects produce weak signals and require high sample densities (1). In contrast, nonlinear techniques probing electric-dipole-allowed effects have been used for sensitive chiral analyses of liquid samples. Influenced by these methods, the researchers carried out nonlinear resonant phase-sensitive microwave spectroscopy of gas-phase samples in the presence of an adiabatically switched nonresonant orthogonal electric field. They used this technique to map the enantiomer-dependent sign of an electric dipole Rabi frequency onto the phase of emitted microwave radiation (1). They describe theoretically how this results in a sensitive and species-selective method for determining the chirality of cold gas-phase molecules. They implemented the approach experimentally to distinguish between the S and R enantiomers of 1,2-propanediol and their racemic mixture. They reported that this technique produced a large and definitive signature of chirality and has the potential to determine the chirality of multiple species in a mixture.

"We can soon measure mixtures of different compounds and determine the enantiomer ratios of each," said Melanie Schnell, co-author of the study in a CFEL release. In a next step, the researchers plan to apply the technique in a broadband spectrometer at CFEL that could then measure the enantiomer ratios in mixtures of substances. In the longer run, the method opens the door to develop a technique for separating enantiomers.

Reference

1. D. Patterson, Melanie Schnell, and John M. Doyle, Nature, 497 (7450), 475-477, 2013.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here